Hims & Hers Sued by FTC Over Data Privacy and Billing; Stock Tumbles

The Federal Trade Commission, joined by California and Utah, has filed a lawsuit against telehealth giant Hims & Hers Health Inc., accusing it of illegally sharing sensitive patient health data with advertising platforms like Meta and Snap, alongside engaging in deceptive billing and difficult cancellation practices. This breaking news sent HIMS stock plummeting by as much as 15% on Wednesday, raising alarms across the digital health sector. The lawsuit alleges Hims & Hers breached its privacy promises by using tracking technologies to send personal health information to third-party advertisers and charged customers for prescriptions almost immediately after they submitted intake forms, without a clear consultation or consent. This move by the FTC is not isolated; it follows previous enforcement actions against other telehealth companies like BetterHelp and Cerebral for similar data sharing violations, signaling a broader regulatory crackdown on privacy and transparency in online health services. While Hims & Hers has vehemently denied the allegations, calling them 'baseless' and vowing to fight them in court, the ongoing legal battle will be a significant test for the company and the wider telehealth industry. Investors are now balancing the immediate market fallout and legal risks against Hims & Hers' strong business fundamentals and subscriber growth, with some seeing the stock's dip as a potential buying opportunity despite the regulatory heat. The outcome of this case could redefine data handling and consumer protection standards for digital healthcare providers, with implications for their profitability and user trust.